Insulin resistance, serum insulin and HOMA-R

Journal of Gastroenterology

Volumn 48, Issue 5, 2013, Pages 673-

  Campanati, A ^a   Ganzetti, G ^a   Di Sario, A ^a   Benedetti, A ^a   Offidani, A ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; GLUCOSE; INSULIN;

CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET RESTRICTION; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPERURICEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LETTER; LIVER FIBROSIS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PSORIASIS; PUVA;

HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MODELS, BIOLOGICAL;

EID: 84878114150     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0769-2     Document Type: Letter

References (3)

1. Campanati A, Ganzetti G, Sario AD, Damiani A, Sandroni L, Rosa L, Benedetti A, Offidani A. The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. J Gastroenterol. 2012 Oct 13. doi: 10.1007/s00535-012-0678-9.
2. Kawada T. Preliminary report: homeostasis model assessment of insulin resistance, an indicator of insulin resistance, is strongly related to serum insulin: practical data presentation and the mathematical basis. Metabolism. 2010;59(7):1044-6.
3. Martinez-Hervas S, Argente C, Garcia-Jodar J, Priego A, Real JT, Carratala A, et al. Misclassification of subjects with insulin resistance and associated cardiovascular risk factors by homeostasis model assessment index. Utility of a postprandial method based on oral glucose tolerance test. Metabolism. 2011;60(5):740-6.